CYTR - CytRx Corporation Stock Trading

CytRx Corporation(NASDAQ: CYTR) stock trading, description, contact, officers and directors.

About CytRx Corporation

Not available

Stock Information

CytRx Corporation Company Name:

CYTR Stock Symbol:

NASDAQ Market:

CytRx Corporation Website:

Get CYTR Alerts

News, Short Squeeze, Breakout and More Instantly...

CYTR - CytRx Notes Orphazyme's Announcement of Topline Results from Trial for Arimoclomol in the Treatment of Inclusion Body Myositis

CytRx Corporation (OTCQB: CYTR) ("CytRx"), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today noted that Orphazyme A/S (NASDAQ: ORPH) ("Orphazyme") announced that its phase 2/3 trial evaluating ari...
CYTR - CytRx Comments on Fiscal Year 2020 Results and Highlights Strategic Progress

CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, today commented on its results for the fourth quarter and fiscal...
CYTR - CytRx Highlights Orphazyme's Momentum Ahead of Potential Regulatory Approval of Arimoclomol for Niemann-Pick Disease Type C

Orphazyme Announces the Global Brand Name for Arimoclomol – MIPLYFFA – Ahead of Prospective FDA and EMA Approvals Expanded its Early Access Program for NPC in the U.S. and Europe as Well as Expectation of European Regulatory Decision by Q4 2021 ...